首页 | 本学科首页   官方微博 | 高级检索  
     


Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target
Authors:Alison M. Kurimchak,Vikas Kumar,Carlos Herrera-Montá  vez,Katherine J. Johnson,Nishi Srivastava,Karthik Davarajan,Suraj Peri,Kathy Q. Cai,Gina M. Mantia-Smaldone,James S. Duncan
Affiliation:1. Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA;2. Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA;3. Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA;4. Division of Gynecologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Abstract:
><ol class=
  • Download : Download high-res image (218KB)
  • Download : Download full-size image
  • Highlights
    • •SRPK1 is overexpressed in endometrial cancer and associated with poor survival.
    • •SRPK1 promotes endometrial cancer cell growth under nutrient-deprived conditions.
    • •Activation of EGFR-IGF1R-AKT signaling promotes resistance to SRPK1 inhibitors.
    • •Co-targeting SRPK1 and EGFR-IGF1R synergize blocking endometrial cancer cell growth.
    Keywords:kinases  cancer biomarker(s)  pathway analysis  affinity proteomics  therapeutic targets  combination therapies  endometrial carcinoma  kinome  splicing  tissue proteomics
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号